Table 1.
Characteristics and COVID-19 clinical spectrum.
| Severity | Univariate | Multivariate Ordinal Logistic Regression (Severe and Critical vs. Others) | ||||
|---|---|---|---|---|---|---|
| Mild (%) | Moderate (%) | Severe and Critical (%) | p-Value | p-Value | aOR with 95% CI | |
| Sex (M/F) | 34/34 | 67/46 | 52/22 | 0.047 * | 0.023 | 1.81 (1.09–3.01) |
| Age (median, IQR) | 51.5 (34) | 64.0 (17) | 70.5 (15) | <0.001 ± | <0.001 | 1.06 (1.04–1.08) |
| Atrial Fibrillation | 17 (25.0) | 32 (28.3) | 33 (44.6) | 0.022 * | 0.787 | 0.92 (0.49–1.71) |
| Respiratory Disease | 5 (7.4) | 13 (11.5) | 14 (18.9) | 0.104 * | 0.325 | 1.47 (0.68–3.15) |
| Coronary Disease | 7 (10.3) | 23 (20.4) | 20 (27.0) | 0.041 * | 0.955 | 1.02 (0.50–2.09) |
| Diabetes | 10 (14.7) | 25 (22.1) | 18 (24.3) | 0.331 * | 0.619 | 0.85 (0.45–1.60) |
| Neoplasia | 7 (10.3) | 11 (9.7) | 11 (14.9) | 0.529 * | 0.209 | 0.61 (0.28–1.32) |
| Hyperlipidemia | 21(30.9) | 60 (53.1) | 32 (43.2) | 0.014 * | 0.138 | 0.65 (0.37–1.15) |
| Hypertension | 24 (35.3) | 62 (54.9) | 56 (75.7) | <0.001 * | 0.104 | 1.67 (0.90–3.08) |
| β-Thalassemia Heterozygotes | 5 (7.4) | 19 (16.8) | 21 (28.4) | 0.004 * | 0.002 | 2.89 (1.49–5.62) |
* Chi-square test, ± Mann–Whitney test; Bold is for the statistically significant results (p-value < 0.05).